Welcome Customer !

Membership

Help

Ilebo Biotechnology (Shanghai) Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products

Ilebo Biotechnology (Shanghai) Co., Ltd

  • E-mail

  • Phone

  • Address

    Room 650, Block B, No. 180 Changjiang South Road, Baoshan District, Shanghai

Contact Now

Collagen+adrenaline induced pulmonary embolism animal model

NegotiableUpdate on 05/06
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

Collagen+adrenaline induced pulmonary embolism animal model: It is a commonly used experimental method, mainly used to simulate the pathophysiological process of human pulmonary embolism

Product Details

Collagen+adrenaline induced pulmonary embolism animal model

Collagen+adrenaline induced pulmonary embolism animal model

1. ‌Experimental animal selection

  • mouse: Commonly used C57BL/6 strain, 8-12 weeks old, weight 20-25g
    .

  • ratLike Sprague Dawley or Wistar strains, weighing 200-250g
    .

  • rabbitFor special experimental needs, weighing 2.5-3.0kg.

2. ‌Drug preparation and dosage

  • collagenThe usual concentration is 2-4mg/ml, and the dose is 430 μ g/kg (for mice) or 5-10ml/kg (for rats)
    .

  • adrenaline: Concentration of 0.1-0.2mg/ml, dosage of 20 μ g/kg (mice) or 0.1-0.2ml/kg (rats)
    .

  • solventDissolve in PBS buffer, ready to use
    .

3. ‌modeling method

  • Injection method‌:

    • Mouse: Tail vein injection
      .

    • Rats: injection via tail vein or internal jugular vein
      .

    • Rabbit: jugular vein injection
      .

  • operating steps‌:

    1. Inject collagen solution first and observe for 5-10 minutes.

    2. Inject adrenaline solution again and slowly push it in
      .

4. ‌Model evaluation indicators

  • clinical manifestationsShortness of breath, flapping of nasal wings, cyanosis, reduced activity, etc
    .

  • Survival rate and timeRecord the time of spontaneous death, and determine death if breathing stops for 1 minute
    .

  • Pathological examinationHE staining shows pulmonary thrombosis and alveolar wall congestion and edema
    .

  • HemodynamicsMonitor blood pressure, heart rate, pulmonary artery pressure, etc. (optional)